Carregant...
Randomized immunotherapy trial in dual‐allergic patients using “active allergen placebo” as control
BACKGROUND: Placebo control in allergen immunotherapy (AIT) trials presents ethical and blinding concerns. We tested a trial design with an “active allergen placebo,” as proposed by ARIA‐GA (2) LEN, to investigate in a double‐blind trial the efficacy and safety of AIT in dual‐allergic patients (gras...
Guardat en:
| Publicat a: | Allergy |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6773203/ https://ncbi.nlm.nih.gov/pubmed/31025363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.13842 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|